Document is current
Any future updates will be listed below
-
Authors
Díez-Gandía, Eva
Gómez-Álvarez, Carla
López-Lacort, Mónica
Muñoz-Quiles, Cintia
Úbeda-Sansano, Isabel
Díez-Domingo, Javier
Orrico-Sánchez, Alejandro
,
Rigual, Fernando Calvo
Vicent, Eva Suarez
Mañes, Carmen
Martí, Elena
Cerdán, Teresa
Arandes, Antonio Soriano
Pavón, Lucia Losada
Sánchez, Airam Álvarez
Furió, Gemma Ricós
Porcuna, Tomás Pérez
Benito, Noemí Magro
Díaz, Javier Martínez
Ortiz, Jessica
Mangas, Ana
García, Mónica
Rovira, Patricia
Urgellés, Marta
Pozuelo, Marta
- License Information
-
More Information
Article History
Received: 14 March 2021
Accepted: 20 August 2021
First Online: 6 September 2021
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and Good Epidemiological Practice. The protocol was reviewed and approved by the Ethics Committee of Hospital Arnau de Vilanova of Valencia. Written informed consent signed by parents or legal representatives was obtained.
: Not applicable.
: EDG, MLL, AOS, CMQ, IUS and JDD received travel grants to attend meetings sponsored by pharmaceutical companies. JDD has been principal investigator in clinical trials sponsored by SPMSD, MSD, GSK and Pfizer. JDD acted as Advisor for GSK and SPMSD and AOS for MSD and GSK. CGA and Study collaborators have no conflict of interest.
